Foresee licenses exclusive global rights related to its MMP-12 inhibitor programs to Primevera Therapeutics, LLC.Foresee will receive a 10 million USD ...
Foresee licenses exclusive global rights related to its MMP-12 inhibitor programs to Primevera Therapeutics, LLC.Foresee will receive a 10 million USD upfront payment, potential milestones of ...
Making civics class relate more to students' lives is working in some US schools and could be fresh approach needed in NC.
OTTAWA — Ontarians can expect a rash of new rules, laws and regulations coming up in 2026. Starting Jan. 1, carbon monoxide ...
BARRACKS AND STRATEGYThe AFP celebrated its 90th foundation anniversary last Dec. 19, 2025, with the theme “AFP @90, Matatag sa Paglilingkod sa Bayan” ...
NVIDIA announced DLSS 4.5, G-SYNC Pulsar monitors availability, RTX Remix Logic, new ACE tech integrations, NVIDIA App updates, nre DLSS 4 titles, more devices and ways to play with GeForce NOW, and ...
Some of Canada's biggest pension plans are seeking to reduce their direct private equity bets, potentially opening up more opportunities for private equity giants Blackstone (BX), KKR (KKR), Apollo ...
Members of a new class of antivirals are being tested in U.S. clinical trials, and one has gained approval in Japan, but how ...
Vietnam Investment Review on MSN
GenEditBio Receives FDA Clearance of IND Application for Its Lead In Vivo Genome-Editing Program GEB-101 for TGFBI Corneal Dystrophy
GenEditBio Limited ("GenEditBio"), a clinical-stage biotechnology startup focusing on genome-editing therapeutic solutions, today announced that the U.S. Food and Drug Administration (FDA) has cleared ...
Investor enthusiasm for the emerging technology surged last year as researchers made major technical breakthroughs ...
Summer nights filled with music, performances, dance and yoga sessions, and movies - all atop a floating stage - will deliver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback